You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin Glargine

Showing 1 - 25 of 8,138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DKA Trial in Saint Paul (Insulin Glargine)

Recruiting
  • DKA
  • Insulin Glargine
  • Saint Paul, Minnesota
    Regions Hospital
Aug 21, 2023

To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children Trial in

Completed
  • To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
  • Glargine and regular insulin versus NPH and regular insulin
  • Lahore, Punjab, Pakistan
    Pediatric endocrine and diabetes section, Pediatric department,
Jan 29, 2023

Type 2 Diabetes Trial (INS068 injection, Insulin Glargine)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • INS068 injection
  • Insulin Glargine
  • (no location specified)
Jan 19, 2023

Diabetes, Type 1 Trial in Santa Barbara, Honolulu (Insulin Degludec, Insulin Glargine, TRESIBA® FLEXTOUCH®)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Insulin Degludec
  • +3 more
  • Santa Barbara, California
  • +1 more
Oct 6, 2022

Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients, Metformin Combined With Insulin Glargine in the

Not yet recruiting
  • Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients
  • +6 more
  • Chiglitazar sodium
  • Chiglitazar placebo
  • Guangzhou, Guangdong, China
    the First Affiliated Hospital of Sun Yat-sen University
Aug 17, 2023

Type 2 Diabetes Trial (INS068 injection, Insulin Glargine)

Not yet recruiting
  • Type 2 Diabetes
  • INS068 injection
  • Insulin Glargine
  • (no location specified)
Jan 17, 2023

Type 2 Diabetes Trial (The needle-free jet injector, Conventional insulin pen)

Completed
  • Type 2 Diabetes
  • The needle-free jet injector
  • Conventional insulin pen
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Oct 25, 2022

Type 2 Diabetes, Glucose, High Blood Trial in Cheonju (IGlarLixi, Dulaglutide)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Glucose, High Blood
  • Cheonju, Chungcheongbuk-do, Korea, Republic of
    Chungbuk National University Hospital
Jul 19, 2022

Type 2 Diabetes Trial in Nanjing (Tirzepatide, Insulin Glargine)

Recruiting
  • Type 2 Diabetes Mellitus
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Sep 21, 2022

Type 2 Diabetes Trial in China (Insulin glargine 300 U/ml)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Insulin glargine 300 U/ml
  • China, China
    Investigational Sites
Jul 15, 2022

Type 2 Diabetes Trial in India (INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010), INSULIN GLARGINE (HOE901), Metformin)

Completed
  • Type 2 Diabetes Mellitus
  • INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010)
  • +3 more
  • Bangalore, India
  • +12 more
Apr 21, 2022

Type 2 Diabetes (T2DM) Trial in Germany

Recruiting
  • Type 2 Diabetes Mellitus (T2DM)
    • Germany, Germany
      Investigational site
    Nov 21, 2022

    Type 2 Diabetes Trial in South Miami (Insulin Glargine, Insulin Aspart, Insulin Lispro)

    Terminated
    • Type 2 Diabetes Mellitus
    • Insulin Glargine
    • +2 more
    • South Miami, Florida
      University of Miami
    Aug 18, 2022

    Glycemic Control and Quality of Life in Type 1 Diabetes During

    Completed
    • Type 1 Diabetes
    • Insulin Glargine 300 UNT/ML [Toujeo]
    • Aalst, Belgium
    • +2 more
    Aug 29, 2022

    Type 2 Diabetes Trial in Shanghai (THDB0206 Injection, Insulin Lispro Injection)

    Recruiting
    • Type 2 Diabetes
    • THDB0206 Injection
    • Insulin Lispro Injection
    • Shanghai, China
      Zhongshan Hospital
    Apr 17, 2023

    Diabetic Ketoacidosis Trial in Baltimore (Early administration of subcutaneous insulin glargine dose, IV insulin infusion, IV

    Completed
    • Diabetic Ketoacidosis
    • Early administration of subcutaneous insulin glargine dose
    • +2 more
    • Baltimore, Maryland
      University of Maryland Medical Center
    Mar 19, 2022

    Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)

    Recruiting
    • Insulin Pump，Continuous Glucose Monitoring Technology
    • Insulin Glargine
    • +3 more
    • Guandong, China
      刘烈华
    Nov 7, 2023

    Type 2 Diabetes Trial in Neuss (Insulin Glargine, LY3209590)

    Active, not recruiting
    • Type 2 Diabetes Mellitus
    • Neuss, Nordrhein-Westfalen, Germany
      Profil Institut für Stoffwechselforschung
    Jul 7, 2022

    Type 2 Diabetes Trial in Jaipur, Nasik (Insulin glargine (U300))

    Recruiting
    • Type 2 Diabetes Mellitus
    • Insulin glargine (U300)
    • Jaipur, India
    • +1 more
    Aug 18, 2022

    Diabetes, Type 2 Trial in Mainz, Neuss (NNC0268-0965, Insulin glargine, Placebo (NNC0268-0965))

    Completed
    • Diabetes Mellitus, Type 2
    • Mainz, Germany
    • +1 more
    Jan 11, 2022

    Diabetes, Type 2 Trial in Graz (insulin icodec, Insulin glargine)

    Completed
    • Diabetes Mellitus, Type 2
    • insulin icodec
    • Insulin glargine
    • Graz, Austria
      Novo Nordisk Investigational Site
    Sep 27, 2022

    Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)

    Recruiting
    • Diabetes Mellitus, Type 2 Treated With Insulin
    • insulin degludec + liraglutide
    • Insulin Glargine - Insulin Aspart
    • Bogotá, Colombia
      Hospital Universitario San Ignacio
    Mar 2, 2023

    Diabetes, Type 1, Type 1 Diabetes Trial in Dhaka, Mwanza (Insulin Glargine, NPH or premixed 70/30 (human insulin))

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • Type 1 Diabetes
    • Insulin Glargine
    • NPH or premixed 70/30 (human insulin)
    • Dhaka, Bangladesh
    • +2 more
    Nov 30, 2022

    Diabetes, Type 2, Obesity Trial in Worldwide (Semaglutide, Insuline glargine (reduced), Insuline glargine (titrated))

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Obesity
    • New Port Richey, Florida
    • +28 more
    Aug 22, 2022

    Type2diabetes Trial in Nasiriyah, Basrah (Insulin Glargine 100 UNT/ML Pen Injector [Lantus], Saxagliptin 2.5 mg/ Metformin

    Not yet recruiting
    • Type2diabetes
    • Insulin Glargine 100 UNT/ML Pen Injector [Lantus]
    • +2 more
    • Nasiriyah, Thi Qar, Iraq
    • +1 more
    Oct 28, 2023